Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Pyelonephritis | Research article

Urinary tract infections in renal transplant recipients at a quaternary care centre in Australia

Authors: Simon OLENSKI, Carla SCUDERI, Alex CHOO, Aneesha Kaur BHAGAT SINGH, Mandy WAY, Lakshmanan JEYASEELAN, George JOHN

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Urinary tract infections (UTI) are the most common of infections after renal transplantation. The consequences of UTIs in this population are serious, with increased morbidity and hospitalisation rates as well as acute allograft dysfunction. UTIs may impair overall graft and patient survival. We aimed to identify the prevalence and risk factors for post-transplant UTIs and assess UTIs’ effect on renal function during a UTI episode and if they result in declining allograft function at 2 years post-transplant. Additionally, the causative organism, the class of antibacterial drug employed for each UTI episode and utilisation rates of trimethoprim/sulfamethoxazole (TMP/SMX) prophylaxis were also quantified.

Methods

This was a retrospective study of 72 renal transplant patients over a 5-year period who were managed at the Royal Brisbane and Women’s Hospital. Patient charts, pathology records and dispensing histories were reviewed as part of this study and all UTIs from 2 years post transplantation were captured.

Results

Of these patients, 20 (27.8%) had at least one UTI. Older age (p = 0.015), female gender (p < 0.001), hyperglycaemia (p = 0.037) and acute rejection episodes (p = 0.046) were risk factors for developing a UTI on unadjusted analysis. Female gender (OR 4.93) and age (OR 1.03) were statistically significant risk factors for a UTI on adjusted analysis. On average, there was a 14.4% (SEM 5.20) increase in serum creatinine during a UTI episode, which was statistically significant (p = 0.027), and a 9.1% (SEM 6.23) reduction in serum creatinine after the UTI episode trending toward statistical significance.
(p = 0.076). Common organisms (Escherichia coli and Klebsiella pneumoniae) accounted for 82% of UTI episodes with 70% of UTI cases requiring only a single course of antibiotic treatment. Furthermore, the antibiotic class used was either a penicillin (49%) or cephalosporin (36%) in the majority of UTIs. The use of TMP/SMX prophylaxis for Pneumocystis carinii pneumonia prophylaxis did not influence the rate of UTI, with > 90% of the cohort using this treatment.

Conclusions

There was no significant change in serum creatinine and estimated glomerular filtrate rate from baseline to 2 years post-transplant between those with and without a UTI.
Literature
1.
go back to reference Castaneda DA, Leon K, Martin R, Lopez L, Perez H, Lozano E. Urinary tract infection and kidney transplantation: a review of diagnosis, causes, and current clinical approach. Transplant Proc. 2013;45(4):1590–2.CrossRef Castaneda DA, Leon K, Martin R, Lopez L, Perez H, Lozano E. Urinary tract infection and kidney transplantation: a review of diagnosis, causes, and current clinical approach. Transplant Proc. 2013;45(4):1590–2.CrossRef
2.
go back to reference Saemann M, Horl WH. Urinary tract infection in renal transplant recipients. Eur J Clin Investig. 2008;38(Suppl 2):58–65.CrossRef Saemann M, Horl WH. Urinary tract infection in renal transplant recipients. Eur J Clin Investig. 2008;38(Suppl 2):58–65.CrossRef
3.
go back to reference Goldman JD, Julian K. Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13507.CrossRef Goldman JD, Julian K. Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13507.CrossRef
4.
go back to reference Fishman JA, Issa NC. Infection in organ transplantation: risk factors and evolving patterns of infection. Infect Dis Clin N Am. 2010;24(2):273–83.CrossRef Fishman JA, Issa NC. Infection in organ transplantation: risk factors and evolving patterns of infection. Infect Dis Clin N Am. 2010;24(2):273–83.CrossRef
5.
go back to reference Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary infections in renal transplant recipients. Transplant Proc. 2006;38(8):2414–5.CrossRef Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary infections in renal transplant recipients. Transplant Proc. 2006;38(8):2414–5.CrossRef
6.
go back to reference Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602.CrossRef Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602.CrossRef
7.
go back to reference Alevizakos M, Nasioudis D, Mylonakis E. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis. 2017;19(6).CrossRef Alevizakos M, Nasioudis D, Mylonakis E. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis. 2017;19(6).CrossRef
8.
go back to reference De Souza RM, Olsburgh J. Urinary tract infection in the renal transplant patient. Nat Clin Pract Nephrol. 2008;4(5):252–64.CrossRef De Souza RM, Olsburgh J. Urinary tract infection in the renal transplant patient. Nat Clin Pract Nephrol. 2008;4(5):252–64.CrossRef
9.
go back to reference Wu X, Dong Y, Liu Y, Li Y, Sun Y, Wang J, et al. The prevalence and predictive factors of urinary tract infection in patients undergoing renal transplantation: a meta-analysis. Am J Infect Control. 2016;44(11):1261–8.CrossRef Wu X, Dong Y, Liu Y, Li Y, Sun Y, Wang J, et al. The prevalence and predictive factors of urinary tract infection in patients undergoing renal transplantation: a meta-analysis. Am J Infect Control. 2016;44(11):1261–8.CrossRef
10.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–155. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–155.
11.
go back to reference Green H, Rahamimov R, Gafter U, Leibovitci L, Paul M. Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis. 2011;13(5):441–7.CrossRef Green H, Rahamimov R, Gafter U, Leibovitci L, Paul M. Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis. 2011;13(5):441–7.CrossRef
12.
go back to reference Singh R, Geerlings SE, Bemelman FJ. Asymptomatic bacteriuria and urinary tract infections among renal allograft recipients. Curr Opin Infect Dis. 2015;28(1):112–6.CrossRef Singh R, Geerlings SE, Bemelman FJ. Asymptomatic bacteriuria and urinary tract infections among renal allograft recipients. Curr Opin Infect Dis. 2015;28(1):112–6.CrossRef
13.
go back to reference Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis. 2006;8(3):140–7.CrossRef Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis. 2006;8(3):140–7.CrossRef
14.
go back to reference Naik AS, Dharnidharka VR, Schnitzler MA, Brennan DC, Segev DL, Axelrod D, et al. Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice. Transpl Int. 2016;29(2):241–52.CrossRef Naik AS, Dharnidharka VR, Schnitzler MA, Brennan DC, Segev DL, Axelrod D, et al. Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice. Transpl Int. 2016;29(2):241–52.CrossRef
15.
go back to reference Abeysekera N, Graver A, Cooley L, Kirkland G, Jose MD. Infectious complications in the Southern Tasmanian kidney transplant population. Nephrology (Carlton, Vic). 2018;24(2019):849–54.CrossRef Abeysekera N, Graver A, Cooley L, Kirkland G, Jose MD. Infectious complications in the Southern Tasmanian kidney transplant population. Nephrology (Carlton, Vic). 2018;24(2019):849–54.CrossRef
16.
go back to reference Galindo Sacristan P, Perez Marfil A, Osorio Moratalla JM, de Gracia GC, Ruiz Fuentes C, Castilla Barbosa YA, et al. Predictive factors of infection in the first year after kidney transplantation. Transplant Proc. 2013;45(10):3620–3.CrossRef Galindo Sacristan P, Perez Marfil A, Osorio Moratalla JM, de Gracia GC, Ruiz Fuentes C, Castilla Barbosa YA, et al. Predictive factors of infection in the first year after kidney transplantation. Transplant Proc. 2013;45(10):3620–3.CrossRef
17.
go back to reference Liu S, Luo G, Sun B, Lu J, Zu Q, Yang S, et al. Early removal of double-J stents decreases urinary tract infections in living donor renal transplantation: a prospective, Randomized Clinical Trial. Transplant Proc. 2017;49(2):297–302.CrossRef Liu S, Luo G, Sun B, Lu J, Zu Q, Yang S, et al. Early removal of double-J stents decreases urinary tract infections in living donor renal transplantation: a prospective, Randomized Clinical Trial. Transplant Proc. 2017;49(2):297–302.CrossRef
18.
go back to reference Shi SH, Kong HS, Xu J, Zhang WJ, Jia CK, Wang WL, et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis. 2009;11(5):405–12.CrossRef Shi SH, Kong HS, Xu J, Zhang WJ, Jia CK, Wang WL, et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis. 2009;11(5):405–12.CrossRef
19.
go back to reference Giral M, Pascuariello G, Karam G, Hourmant M, Cantarovich D, Dantal J, et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int. 2002;61(5):1880–6.CrossRef Giral M, Pascuariello G, Karam G, Hourmant M, Cantarovich D, Dantal J, et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int. 2002;61(5):1880–6.CrossRef
20.
go back to reference Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transpl. 2013;18:195–204.CrossRef Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transpl. 2013;18:195–204.CrossRef
21.
go back to reference Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis. 2004;44(2):353–62.CrossRef Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis. 2004;44(2):353–62.CrossRef
22.
go back to reference Alangaden G. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep. 2007;9(6):475–9.CrossRef Alangaden G. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep. 2007;9(6):475–9.CrossRef
23.
go back to reference Origuen J, Lopez-Medrano F, Fernandez-Ruiz M, Polanco N, Gutierrez E, Gonzalez E, et al. Should asymptomatic Bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2016;16(10):2943–53.CrossRef Origuen J, Lopez-Medrano F, Fernandez-Ruiz M, Polanco N, Gutierrez E, Gonzalez E, et al. Should asymptomatic Bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2016;16(10):2943–53.CrossRef
Metadata
Title
Urinary tract infections in renal transplant recipients at a quaternary care centre in Australia
Authors
Simon OLENSKI
Carla SCUDERI
Alex CHOO
Aneesha Kaur BHAGAT SINGH
Mandy WAY
Lakshmanan JEYASEELAN
George JOHN
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1666-6

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine